Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
LTM | 7 AUD its not the same like 17 AUD! :) | 10:56 | 63 | 26K | |||
|
|||||||
LTM | EV and battery thread | 09:21 | 225 | 77K | |||
|
|||||||
LTM | General Discussion | 04:57 | 1.3K | 574K | |||
|
|||||||
LTM | LTM Charts | 26/04/24 | 7 | 2.7K | |||
|
|||||||
LTM | View from Space | 26/04/24 | 37 | 17K | |||
|
|||||||
LTM | Chart tech analysis | 24/04/24 | 120 | 52K | |||
|
|||||||
LTM | Ni announcement on ASX at all ?? | 19/04/24 | 7 | 2.5K | |||
|
|||||||
LTM | Ann: Form 10-K Annual Report | 17/04/24 | 17 | 7.9K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |